Dr Margaret Tempero

Margaret tempero

Overview

Dr. Tempero is Director, UCSF Pancreas Center and Leader of the UCSF Pancreas Cancer Program. She oversees a full portfolio of projects from risk assessment to early detection, biology, and therapeutics in pancreatic neuroendocrine tumors and pancreatic ductal adenocarcinoma. Her personal research career has focused on pancreatic ductal adenocarcinoma, especially in the area of investigational therapeutics. She was a pioneer in the use of antibody-based therapies and helped develop the fixed dose rate concept for gemcitabine. Her group has developed effective gemcitabine combinations and provided a foundation for using CA19-9 as a surrogate for survival in clinical trials, and currently is assessing molecular subtypes and molecular enrichment for selecting new drugs for clinical evaluation.